全球药品折扣卡市场按类型、治疗类别、销售管道和地区划分

预计 2025 年全球药品折扣卡市场规模为 19.562 亿美元，到 2032 年将达到 33.744 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 8.1%。

药品折扣卡已成为消费者节省处方药费用的热门方式。随着医疗费用的上涨，这些折扣卡为个人和家庭提供了急需的经济援助。其原理很简单：在参与活动的药局出示您的药品折扣卡，即可享有处方笺折扣价。

市场动态：

药品折扣卡市场的发展受到多种因素的驱动。首先，人们对平价医疗方案的需求日益增长，这导致了药品折扣卡的激增。医疗成本的上涨和处方笺药价格的居高不下，促使消费者积极寻求节省药费的方法。

推动这一市场发展的另一个因素是慢性病的普遍性。随着慢性病患者人数的不断增加，处方药的需求也随之增加。药品折扣卡为依赖药物治疗的患者提供了方便且经济实惠的解决方案。

然而，市场中存在一些限制因素。药品折扣卡面临的挑战之一是并非所有药局都接受。虽然许多大型药局接受这些卡，但仍有一些小型药局不参与此类计画。对于喜欢使用本地或独立药局的消费者来说，这种有限的接受度可能是一个障碍。

儘管面临诸多挑战，药品折扣卡市场仍蕴含着巨大的机会。数位平台和行动应用程式的推出，让消费者更容易取得和使用这些卡片。随着智慧型手机的普及和行动应用程式的便利性，药品折扣卡可以被更广泛的受众接受，并为消费者带来更多价值。

本研究的主要特点

• 本报告对全球药品折扣卡市场进行了详细分析，包括预测期 2025-2032 的市场规模和复合年增长率（假设 2024 年为基准年）。
• 它探索了各个领域的潜在收益成长机会，并为该市场提出了引人注目的投资提案矩阵。
• 市场洞察：包括对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势和驱动因素、区域展望以及主要企业采用的竞争策略的关键考虑因素。
• 公司简介：根据公司亮点、产品组合、财务表现和策略等参数，对药品折扣卡市场的主要企业（如 GoodRx、SingleCare、WellCard Savings、RxSaver、Optum Perks、Kroger Prescription Savings Club、ScriptSave、Walmart Rx Savings Program、Prescription Hope、 产品系列 N Human.Need）进行介绍。
• 这项研究将帮助负责人和经营团队就产品发布、产品升级、市场扩张和行销策略做出明智的决策。
• 本报告涉及行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 已经使用了各种策略矩阵来分析全球药品折扣卡市场，以方便相关人员做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
• 处方药价格高
• 大量人口未投保者或保险不足
• 线上平台的采用率提高
• 州政府参与提供药品折扣
  • 限制因素
• 关键人群缺乏意识
• 药品和政府折扣计划
  • 机会
• 拓展新兴市场
• 非处方药折扣卡
• 为雇主提供客製化服务
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章 药品折扣卡市场：COVID-19 疫情的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年药品折扣卡市场类型

• 品牌卡
• 非专利卡

6. 2020 年至 2032 年按治疗类别分類的药品折扣卡市场

• 心血管药物
• 糖尿病药物
• 止痛药
• 精神科药物
• 抗癌药物
• 其他的

7. 2020 年至 2032 年药品折扣卡市场（依销售管道）

• 在线的
• 离线
• 老年人
• 其他的

8. 2020 年至 2032 年各地区药品折扣卡市场

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 以色列
  • 北非
  • 中部非洲
  • 其他中东和非洲地区

第九章 竞争态势

• GoodRx
• SingleCare
• WellCard Savings
• RxSaver
• Optum Perks
• Kroger Prescription Savings Club
• ScriptSave
• Walmart Rx Savings Program
• Prescription Hope
• FamilyWize
• NeedyMeds
• Humana

第 10 章 章节

• 调查方法
• 关于出版商

Drug Discount Card Market is estimated to be valued at USD 1,956.2 Mn in 2025 and is expected to reach USD 3,374.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

Drug discount cards have become a popular way for consumers to save money on prescription medications. With rising healthcare costs, these discount cards offer a much-needed financial relief to individuals and families. The concept is simple - individuals can present their drug discount card at participating pharmacies to receive discounted prices on their prescriptions.

Market Dynamics:

The drug discount card market is driven by several factors. Firstly, the increasing need for affordable healthcare options has led to a rise in the adoption of drug discount cards. With rising healthcare costs and high prescription drug prices, consumers are actively searching for ways to save money on their medications.

Another driver of this market is the growing prevalence of chronic diseases. As the number of individuals with chronic illnesses continues to rise, so does the demand for prescription medications. Drug discount cards provide an accessible and affordable solution for individuals who rely on medication to manage their conditions.

However, there are also certain restraints in the market. One of the challenges faced by drug discount cards is the lack of acceptance at all pharmacies. While many major pharmacies accept these cards, there are still some smaller pharmacies that do not participate in such programs. This limited acceptance can be a barrier for consumers who prefer to use local or independent pharmacies.

Despite these challenges, there are significant opportunities in the drug discount card market. The implementation of digital platforms and mobile applications has made it easier for consumers to access and use these cards. With the increasing adoption of smartphones and the convenience of mobile apps, drug discount cards can reach a wider audience and provide even more value to consumers.

Key features of the study:

• The report provides an in-depth analysis of the global drug discount card market including market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• The study explores potential revenue growth opportunities across different segments and presents attractive investment proposition matrices for this market
• Market Insights: The report presents key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Company Profiles: Key players in the drug discount card market, such as GoodRx, SingleCare, WellCard Savings, RxSaver, Optum Perks, Kroger Prescription Savings Club, ScriptSave, Walmart Rx Savings Program, Prescription Hope, and FamilyWize, NeedyMeds and Humana are profiled based on parameters like company highlights, product portfolio, financial performance, and strategies
• The study assists marketers and management authorities in making informed decisions regarding product launches, product upgrades, market expansion, and marketing tactics
• The report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Various strategy matrices have been used in analyzing the global drug discount card market to provide stakeholders with ease in decision-making

Drug Discount Card Market Segmentation:

• Drug Discount Card Market, By Type
  • Branded Cards
  • Generic Cards
• Drug Discount Card Market, By Therapeutic Category:
  • Cardiovascular drugs
  • Diabetes drugs
  • Pain medications
  • Mental health medications
  • Cancer drugs
  • Others
• Drug Discount Card Market, By Sales Channel
  • Online
  • Offline
• Drug Discount Card Market, By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize
  • NeedyMeds
  • Humana

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Drug Discount Card, By Type
  • Market Drug Discount Card, By Therapeutic Category
  • Market Drug Discount Card, By Sales Channel
  • Market Drug Discount Card, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• High Cost of Prescription Drugs
• Large Uninsured and Underinsured Population
• Increasing Online Adoption of Online Platform
• Involvement of State Governments to Provide Drug Discounts
  • Restraints
• Lack of Awareness among Key Demographics
• Discount Programs by Pharmaceutical Companies as well as Government Organizations
  • Opportunities
• Expansion into Emerging Markets
• Discount Cards for OTC Drugs
• Customized Services for Employers
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Drug Discount Card Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Drug Discount Card Market, By Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Branded Cards
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
• Generic Cards
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Drug Discount Card Market, By Therapeutic Category, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cardiovascular drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Diabetes drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Pain medications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Mental health medications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Cancer drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Drug Discount Card Market, By Sales Channel, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Online
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Offline
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Senior Citizens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

8. Drug Discount Card Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Category, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Mn)
    • GCC
    • Israel
    • North Africa
    • Central Africa
    • Rest of Middle East & Africa

9. Competitive Landscape

• GoodRx
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SingleCare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• WellCard Savings
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• RxSaver
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Optum Perks
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Kroger Prescription Savings Club
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ScriptSave
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Walmart Rx Savings Program
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Prescription Hope
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• FamilyWize
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NeedyMeds
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Humana
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us